These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7260651)

  • 41. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
    Bongiovanni R; Young D; Newbould E; Jaskiw GE
    Brain Res; 2006 Oct; 1115(1):26-36. PubMed ID: 16934236
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diminished regulation of mesolimbic dopaminergic activity in rat after chronic inorganic lead exposure.
    Lasley SM; Lane JD
    Toxicol Appl Pharmacol; 1988 Sep; 95(3):474-83. PubMed ID: 3188011
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced dopaminergic binding during aging in the rodent striatum.
    Severson JA; Finch CE
    Brain Res; 1980 Jun; 192(1):147-62. PubMed ID: 6155174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantification and pharmacological characterization of dialysate levels of noradrenaline in the striatum of freely-moving rats: release from adrenergic terminals and modulation by alpha2-autoreceptors.
    Gobert A; Billiras R; Cistarelli L; Millan MJ
    J Neurosci Methods; 2004 Dec; 140(1-2):141-52. PubMed ID: 15589344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ontogeny of dopaminergic function in the rat midbrain tegmentum, corpus striatum and frontal cortex.
    Noisin EL; Thomas WE
    Brain Res; 1988 Jun; 469(1-2):241-52. PubMed ID: 3401800
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists.
    Martin GE; Williams M; Haubrich DR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):298-304. PubMed ID: 6813451
    [No Abstract]   [Full Text] [Related]  

  • 48. Dopamine autoreceptor agonists: resolution and pharmacological activity of 2,6-diaminotetrahydrobenzothiazole and an aminothiazole analogue of apomorphine.
    Schneider CS; Mierau J
    J Med Chem; 1987 Mar; 30(3):494-8. PubMed ID: 3820220
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered response to cessation of nerve impulse flow in dopamine neurons after chronic ethanol administration.
    Liljequist S; Engel J
    Adv Exp Med Biol; 1980; 126():157-63. PubMed ID: 6773305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological properties of presynaptic dopamine receptor agonists.
    Carlsson A
    Psychopharmacology Suppl; 1985; 2():31-8. PubMed ID: 3858802
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic gamma-butyrolactone (GBL) treatment: a potential model of dopamine hypoactivity.
    Nowycky MC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Nov; 309(3):247-54. PubMed ID: 43476
    [No Abstract]   [Full Text] [Related]  

  • 52. Presynaptic dopamine receptors. Development of supersensitivity following treatment with fluphenazine decanoate.
    Nowycky MC; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Nov; 300(3):247-54. PubMed ID: 600312
    [No Abstract]   [Full Text] [Related]  

  • 53. Altered activation of tyrosine hydroxylation by gamma-butyrolactone following chronic ethanol treatment.
    Liljequist S
    Drug Alcohol Depend; 1979; 4(3-4):261-3. PubMed ID: 43241
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine hypoactivity measured by in vivo voltammetry.
    Broxterman HJ; Mos J
    Eur J Pharmacol; 1980 Dec; 68(3):389-91. PubMed ID: 7202499
    [No Abstract]   [Full Text] [Related]  

  • 55. Differential Dopamine Dynamics in Adolescents and Adults.
    Toth B
    J Neurosci; 2022 Apr; 42(14):2853-2855. PubMed ID: 35387880
    [No Abstract]   [Full Text] [Related]  

  • 56. Cocaine-induced reinstatement of a conditioned place preference in developing rats: involvement of the d2 receptor.
    Badanich KA; Kirstein CL
    Brain Sci; 2012 Oct; 2(4):573-88. PubMed ID: 24961261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement of behavioral sensitization, anxiety-like behavior, and hippocampal and frontal cortical CREB levels following cocaine abstinence in mice exposed to cocaine during adolescence.
    Valzachi MC; Teodorov E; Marcourakis T; Bailey A; Camarini R
    PLoS One; 2013; 8(10):e78317. PubMed ID: 24205196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postnatal manganese exposure does not alter dopamine autoreceptor sensitivity in adult and adolescent male rats.
    McDougall SA; Mohd-Yusof A; Kaplan GJ; Abdulla ZI; Lee RJ; Crawford CA
    Eur J Pharmacol; 2013 Apr; 706(1-3):4-10. PubMed ID: 23458069
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low dose effects in psychopharmacology: ontogenetic considerations.
    Spear LP; Varlinskaya EI
    Nonlinearity Biol Toxicol Med; 2005 Jan; 3(1):97-111. PubMed ID: 19330157
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of adolescent exposure to cocaine on locomotor activity and extracellular dopamine and glutamate levels in nucleus accumbens of DBA/2J mice.
    Camarini R; Griffin WC; Yanke AB; Rosalina dos Santos B; Olive MF
    Brain Res; 2008 Feb; 1193():34-42. PubMed ID: 18178178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.